Anirvan Ghosh, Chief Executive Officer at Unity Biotechnology, Inc. (UBX), sold 1,183 shares at $1.71 ($2K) on 2024-01-30, disclosed to the SEC on 2024-01-31.
Scheduled sale ($2k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UBX | SELL | 2024-11-06 | $557 | — | Filing → |
| UBX | SELL | 2024-08-06 | $924 | — | Filing → |
| UBX | SELL | 2024-06-26 | $2K | — | Filing → |